All cheat sheets

Australian context · reviewed November 2026

PBS, TGA and prescribing in dermatology

How medicines are approved, subsidised and restricted shapes almost every dermatology management answer: isotretinoin, biologics, off-label use.

What to know

TGA
The Therapeutic Goods Administration approves medicines for use in Australia (registered on the ARTG). Unapproved medicines can be accessed through the Special Access Scheme or the Authorised Prescriber scheme.
PBS
The Pharmaceutical Benefits Scheme subsidises listed medicines. Many dermatology drugs are restricted benefits or Authority Required, with criteria the patient must meet and that must be documented.
Biologics for psoriasis
PBS-subsidised for severe chronic plaque psoriasis under Authority Required listings, with criteria including disease severity and response to earlier treatment. Know the shape of the criteria and that they are re-checked for continuation.
Isotretinoin
Teratogenic. Prescribing of oral isotretinoin is restricted in Australian states and territories, generally to specialists such as dermatologists. Contraception, pregnancy testing, mood and lipid monitoring are expected in your answer.
Off-label prescribing
Common in dermatology. Needs a sound evidence base, informed consent that it is off label, and awareness the patient may pay full price.

How panels probe it

  • “A patient with severe psoriasis wants a biologic. What has to happen before you can prescribe it on the PBS?”
  • “Talk me through starting isotretinoin in a 22-year-old woman.”
  • “A drug you used at home is not available in Australia. What are your options?”

Sample question

How would you start isotretinoin for a young woman with nodular acne?

A framework for your answer

  1. Confirm indication and severity; explore impact and mental health history.
  2. Teratogenicity: pregnancy test, reliable contraception, counselling, documented.
  3. Baseline and monitoring bloods (lipids, liver function); dose plan.
  4. Mood: screen at baseline and follow-up; safety-net.
  5. Consent covering material risks; PBS and state prescribing rules; follow-up plan.
Answer questions like this aloud, freeMarked against an Australian-practice rubric, with follow-ups.

Where candidates lose marks

  • Quoting another country’s rules (for example iPLEDGE) as if they apply here.
  • Forgetting cost and access for the patient.
  • Off-label use without telling the patient.

Read the source

A study summary, not legal or regulatory advice. Laws, PBS listings, MBS items and Board standards change; check the source before relying on a detail.

Further reading on Medbrella